Modern Approach to Alcoholic Liver Disease

References

• Lelbach W K. Epidemiology of alcoholic liver disease. Prog Liv Dis 1976; 5: 494–515
   PubMedGoogle Scholar
• Krasner N, Davis M, Portmann B, et al. Changing patterns of alcoholic liver disease in Great Britain: relation to sex and signs of autoimmunity. Br Med J 1977; 1: 1497–1500
   PubMed Web of Science ®Google Scholar
• Frezza M, Di Padova C, Pozzato G, et al. High blood alcohol levels in women. N Engl J Med 1990; 332: 95–9
   Google Scholar
• Hernandez-Munoz R, Caballeria J, Baraona E, et al. Human gastric alcoholic dehydrogenase: its inhibition by H2-receptor antagonists, and its effect on the bioavailability of ethanol. Alcohol Clin Exp Res 1990; 14: 946–50
   PubMed Web of Science ®Google Scholar
• Caballería J, Baraona E, Deulofeu R, et al. Effects of H2-receptor antagonists on gastric alcohol dehydrogenase activity. DigDisSci 1991; 36: 1673–9
   Google Scholar
• Roin R, Gentry T, Hernádez-Munóz R, et al. Aspirin increases blood alcohol concentrations in humans after ingestion of ethanol. JAMA 1990; 264: 2406–8
   PubMedGoogle Scholar
• Vidal F, Perez J, Morancho, et al. Hepatic alcohol dehydrogenase activity in alcoholic subjects with and without liver disease. Gut 1990; 31: 707–11
   PubMed Web of Science ®Google Scholar
• Panés J, Soler X, Parés A, et al. Influence of liver disease on hepatic alcohol and aldehyde dehydrogenases. Gastroenterology 1989; 97: 708–14
   PubMedGoogle Scholar
• Takase S, Takada A, Yasuhara, Tsutsumi M. Hepatic aldehyde dehydrogenase activity in liver diseases, with particular emphasis on alcoholic liver disease. Hepatology 1989; 9: 704–9
   PubMedGoogle Scholar
• Ehrig T, Bosron W F, Li T-K. Alcohol and aldehyde dehydrogenase. Alcohol Alcoholism 1990; 25: 106–15
   Google Scholar
• Couzigou P, Fleury B, Groppi A, et al. Role of alcohol dehydrogenase polymorphism in ethanol metabolism and alcohol-related diseases. Adv Exp Med Biol 1991; 284: 263–70
   PubMedGoogle Scholar
• Enomoto N, Takase S, Takada N, Takada A. Alcoholic liver disease in heterozygotes of mutant and normal aldehyde dehydrogenase-2 genes. Hepatology 1991; 13: 1071–5
   PubMed Web of Science ®Google Scholar
• Day C P, Bashir R, James O FW, et al. Investigation of the role of polymorphisms at the alcohol and aldehyde dehydrogenase loci in genetic predisposition to alcohol-related end-organ damage. Hepatology 1991; 14: 798–801
   PubMed Web of Science ®Google Scholar
• Maly I P, Sasse D. Intraacinar profiles of alcohol dehydrogenase and aldehyde dehydrogenase activities in human liver. Gastroenterology 1991; 101: 1716–23
   PubMedGoogle Scholar
• Milman N, Graudal N, Strøm P, Franzmann M-B. Alcoholic hepatitis in females. Acta Med Scand 1988; 223: 119–24
   PubMedGoogle Scholar
• Nanji A A, Tsukamotoo H, French S W. Relationship between fatty liver and subsequent development of necrosis, inflammation and fibrosis in experimental alcoholic liver disease. Exp Mol Pathol 1989; 51: 141–8
   PubMedGoogle Scholar
• Nanji A A, Mendenhall C L, French S W. Beef fat prevents alcoholic liver disease in the rat. Alcohol Clin Res 1989; 13: 15–9
   PubMed Web of Science ®Google Scholar
• Degli-Esposti S, Frizell E, He O, et al. Improved rat model of alcoholic liver disease: omega-3-fatty acids plus ethanol administration. Hepatology 1991; 14: 132A, abstract
   Google Scholar
• Smith S L, Jennett R B, Sorrell M F, et al. Acetaldehyde sto-chiometrically inhibits neurotubulin polymerization. J Clin Invest 1989; 84: 337–41
   PubMed Web of Science ®Google Scholar
• Matsuda Y, Takada A, Takase S, Sato H. Accumulation of glycoprotein in the golgi apparatus of hepatocytes in alcoholic liver injuries. Am J Gastroenterol 1991; 86: 854–60
   PubMedGoogle Scholar
• Lin R C, Lumeng L. Formation of 37KD protein-acetaldehyde adduct in liver during alcohol treatment is dependent on alcohol dehydrogenase activity. Alcohol Clin Exp Res 1990; 14: 766–70
   PubMedGoogle Scholar
• Lin R C, Fillenwarth J, Minter R, Lumeng L. Formation of the 37-kD protein-acetaldehyde adduct in primary cultured rat hepatocytes exposed to alcohol. Hepatology 1990; 11: 401–7
   PubMedGoogle Scholar
• Lin R C, Lumeng L, Shahidi S, et al. Protein-acetaldehyde adducts in serum of alcoholic patients. Alcohol Clin Exp Res 1990; 14: 438–43
   PubMedGoogle Scholar
• Niemelä O, Israel Y, Mizoi Y, et al. Hemoglobin-acetaldehyde adducts in human volunteers following acute ethanol ingestion. Alcohol Clin Exp Res 1990; 14: 838–41
   PubMedGoogle Scholar
• Niemelä O, Juvonen T, Parkkila S. Immunohistochemical demonstration of acetaldehyde-modified epitopes in human liver after alcohol consumption. J Clin Invest 1991; 87: 1367–74
   PubMed Web of Science ®Google Scholar
• Hoerner M, Behrens U J, Worner T M, et al. The role of alcoholism and liver disease in the appearance of serum antibodies against acetaldehyde adducts. Hepatology 1988; 8: 569–74
   PubMed Web of Science ®Google Scholar
• Izumi N, Sakai Y, Koyama W, Hasumura Y. Clinical significance of serum antibodies against alcohol-altered hepatocyte membrane in alcoholic liver disease. Alcohol Clin Exp Res 1989; 13: 762–5
   PubMedGoogle Scholar
• Worrall S, De Jersey J, Shanley B C, Wilce P A. Antibodies against acetaldehyde-modified epitopes: an elevated IgA response in alcoholics. Eur J Clin Invest 1991; 21: 90–5
   PubMedGoogle Scholar
• Bailey R J, Krasner N, Feddleston A L, et al. Histocompatibility antigens, autoantibodies, and immunoglobulins in alcoholic liver disease. Br Med J 1976; 2: 727–9
   PubMed Web of Science ®Google Scholar
• Gluud C, Tage-Jensen U, Rubinstein E, Henriksen J H. Autoantibodies and immunoglobulins in patients with alcoholic cirrhosis. Digestion 1984; 30: 1–6
   PubMedGoogle Scholar
• Laskin C A, Vidins E, Blendis L M, Soloninka C A. Autoantibodies in alcoholic liver disease. Am J Med 1990; 89: 129–33
   PubMed Web of Science ®Google Scholar
• Gluud C, Tage-Jensen U. Autoantibodies and immunoglobulins in alcoholic steatosis and cirrhosis. Acta Med Scand 1983; 214: 61–6
   PubMedGoogle Scholar
• Gluud C, Jans H. Circulating immune complexes and complement concentrations in patients with alcoholic liver disease. J Clin Pathol 1982; 35: 380–4
   PubMedGoogle Scholar
• Lomax-Smith J D, Zabrowarny L A, Howarth G S, et al. The immunochemical characterization of mesangial IgA deposits. Am J Pathol 1983; 113: 359–64
   PubMed Web of Science ®Google Scholar
• Van de Wiel A, Van Hattum J, Schuurman H-J, Kater L. Immunoglobulin A in the diagnosis of alcoholic liver disease. Gastroenterology 1988; 94: 457–62
   PubMed Web of Science ®Google Scholar
• Zetterman R K. Autoimmune manifestations of alcoholic liver disease. Autoimmune liver iseases, E L Krawitt, R H Wiesner. Raven Press, New York 1991; 247–60
   Google Scholar
• Perperas A, Tsantoulas D, Portmann B, Feddleston A L, Williams R. Autoimmunity to a liver membrane lipoprotein and liver damage in alcoholic liver disease. Gut 1981; 22: 149–52
   PubMedGoogle Scholar
• Zetterman R K, Luisada-Opper A, Leevy C M. Alcoholic hepatitis: cell-mediated immunologic response to alcoholic hyalin. Gastroenterology 1976; 70: 382–4
   PubMed Web of Science ®Google Scholar
• Izumi N, Sakai Y, Koyama W, Hasumura Y. Clinical significance of serum antibodies against alcohol-altered hepatocyte membrane in alcoholic liver disease. Alcohol Clin Exp Res 1989; 13: 762–5
   PubMedGoogle Scholar
• Trudell J R, Ardies C M, Anderson W R. Cross-reactivity of antibodies raised against acetaldehyde adducts of protein with acetaldehyde adducts of phosphatidyl-ethanolamine: possible role in alcoholic cirrhosis. Mol Pharm 1990; 38: 587–93
   Google Scholar
• Thiele D L. Tumor necrosis factor, the acute phase response and the pathogenesis of alcoholic liver disease. Hepatology 1989; 9: 497–9
   PubMedGoogle Scholar
• McClain C J, Cohen D A. Increased tumor necrosis factor production by monocytes in alcoholic hepatitis. Hepatology 1989; 9: 349–51
   PubMed Web of Science ®Google Scholar
• Felver M E, Mezey E, McGuire M, et al. Plasma tumor necrosis factor a-predicts decreased long-term survival in severe alcoholic hepatitis. Alcohol Clin Exp Res 1990; 14: 255–9
   PubMed Web of Science ®Google Scholar
• Bird G LA, Sheron N, Goka A KJ, Alexander G J, Williams R S. Increased plasma tumor necrosis factor in severe alcoholic, hepatitis. Ann Intern Med 1990; 112: 917–20
   PubMed Web of Science ®Google Scholar
• Deviere J, Content J, Denys C, et al. Excessive in vitro bacterial lipopolysaccharide-induced production of monokines in cirrhosis. Hepatology 1990; 4: 628–34
   Google Scholar
• Khoruts A, Stahnke L, McClain C J, et al. Circulating tumor necrosis factor, interleukin-1 and interleukin-6 concentrations in chronic alcoholic patients. Hepatology 1991; 13: 267–76
   PubMed Web of Science ®Google Scholar
• Deviere J, Content J, Denys C, et al. High interleukin-6 serum levels and increased production by leucocytes in alcoholic liver cirrhosis. Correlation with IgA serum levels and lymphokines production. Clin Exp Immunol 1989; 77: 221–5
   PubMed Web of Science ®Google Scholar
• Sheron N, Bird G, Goka J, et al. Elevated plasma interleukin-6 and increased severity and mortality in alcoholic hepatitis. Clin Exp Immunol 1991; 84: 449–53
   PubMed Web of Science ®Google Scholar
• McMahon B J, Wainwright K, Bulkow L, et al. Response to hepatitis B vaccine in Alaska natives with chronic alcohlism compared with non-alcoholic control subjects. Am J Med 1990; 88: 460–4
   PubMedGoogle Scholar
• Mendenhall C L, Seeff L, Diehl A M, et al. Antibodies to hepatitis B virus and hepatitis C virus in alcoholic hepatitis and cirrhosis: their prevalence and clinical relevance. Hepatology 1991; 14: 581–9
   PubMed Web of Science ®Google Scholar
• Takahashi T, Kamimura T, Asakura H, Ichida F. Hepatic lesions in alcoholic HBV carriers. Dig Dis Sci 1991; 36: 1234–42
   PubMedGoogle Scholar
• Estaban J I, Estaban R, Viladomiu L, et al. Hepatitis C virus antibodies among high risk groups in Spain. Lancet 1989; 2: 294–6
   PubMedGoogle Scholar
• Bode J C, Biermann J, Kohse K P, et al. High incidence of antibodies to hepatitis C virus in alcoholic cirrhosis: fact or fiction?. Alcohol Alcoholism 1991; 26: 111–4
   PubMedGoogle Scholar
• Takase S, Takada N, Enomoto N, et al. Different types of chronic hepatitis in alcoholic patients: does chronic hepatitis induced by alcohol exist?. Hepatology 1991; 13: 876–81
   PubMed Web of Science ®Google Scholar
• Caldwell S H, Jeffers L J, Ditomaso A, et al. Antibody to hepatitis C is common among patients with alcoholic liver disease with and without risk factors. Am J Gastroenterol 1991; 86: 1219–23
   PubMedGoogle Scholar
• Nishiguchi S, Kuroki T, Yabusako T, et al. Detection of hepatitis C virus antibodies and hepatitis C virus RNA in patients with alcoholic liver disease. Hepatology 1991; 14: 985–9
   PubMed Web of Science ®Google Scholar
• Pares A, Barrera J M, Caballeria J, et al. Hepatitis C virus antibodies in chronic alcoholic patients: association with severity of liver injury. Hepatology 1990; 12: 1295–9
   PubMed Web of Science ®Google Scholar
• Goldberg S J, Mendenhall C L, Connell A M, et al. ‘Nonalcoholic’ chronic hepatitis in the alcoholic. Gastroenterology 1977; 72: 598–604
   PubMed Web of Science ®Google Scholar
• Nei J, Matsuda Y, Takada A. Chronic hepatitis induced by alcohol. Dig Dis Sci 1983; 28: 207–15
   PubMed Web of Science ®Google Scholar
• Bird G LA, Williams R. Treatment of advanced alcoholic liver disease. Alcohol Alcoholism 1990; 25: 197–206
   PubMedGoogle Scholar
• Cabre E, Gonzalez-Huix F, Abad-Lacruz A, et al. Effect of total enteral nutrition on the short-term outcome of severely malnourished cirrhotics. Gastroenterology 1990; 98: 715–20
   PubMed Web of Science ®Google Scholar
• Mezey E, Caballeria J, Mitchell M C. Effect of parenteral amino acid supplementation on short-term and long-term outcomes in severe alcoholic hepatitis: a randomized controlled trial. Hepatology 1991; 14: 1090–6
   PubMed Web of Science ®Google Scholar
• Mendenhall C L, Anderson S, Garcia-Pont P, et al. Short-term and long-term survival in patients with alcoholic hepatitis treated with oxandrolone and prednisolone. N Engl J Med 1984; 311: 1464–70
   PubMed Web of Science ®Google Scholar
• Bonkovsky H L, Fiellin D A, Smith G S, et al. A randomized, controlled trial of treatment of alcoholic hepatitis with parenteral nutrition and oxandrolone. I. Short-term effects on liver function. Am J Gastroenterol 1991; 86: 1200–8
   PubMed Web of Science ®Google Scholar
• Bonkovsky H L, Singh R H, Jafri I H, et al. A randomized, controlled trial of treatment of alcoholic hepatitis with parenteral nutrition and oxandrolone. II. Short-term effects on nitrogen metabolism, metabolic balance, and nutrition. Am J Gastroenterol 1991; 86: 1209–18
   PubMedGoogle Scholar
• Bird G, Lau J YN, Koskinas J, et al. Insulin and glucagon infusion in acute alcoholic hepatitis: a prospective randomized controlled trial. Hepatology 1991; 14: 1097–101
   PubMed Web of Science ®Google Scholar
• Trinchet J-C, Balkau B, Poupon R E, et al. Treatment of severe alcoholic hepatitis by infusion of insulin and glucagon: a multi-center sequential trial. Hepatology 1992; 15: 76–81
   PubMed Web of Science ®Google Scholar
• Baker A L, Jaspan J B, Haines N W, et al. A randomized clinical trial of insulin and glucagon infusion for treatment of alcoholic hepatitis: a progress report in 50 patients. Gastroenterology 1981; 80: 1410–14
   PubMed Web of Science ®Google Scholar
• Feher J, Cornides A, Romany A, et al. A prospective multicentre study of insulin and glucagon infusion therapy of acute alcoholic hepatitis. J Hepatol 1987; 5: 224–31
   PubMed Web of Science ®Google Scholar
• Imperiale T F, McCullough A J. Do corticosteroids reduce mortality from alcoholic hepatitis?. Ann Intern Med 1990; 113: 299–307
   PubMed Web of Science ®Google Scholar
• Schwartzman K. In vino Veritas? Alcoholics and liver transplantation. Can J Med 1989; 141: 1262–1265
   Google Scholar
• Schenker S. Should patients with end-stage alcoholic liver disease have a new liver?. Hepatology 1990; 11: 314–9
   PubMed Web of Science ®Google Scholar
• Moss A H, Siegler M. Should alcoholics compete equally for liver transplantation?. JAMA 1991; 265: 1295–8
   PubMed Web of Science ®Google Scholar
• Cohen C, Benjamin M. Alcoholics and liver transplantation. JAMA 1991; 265: 1299–301
   PubMed Web of Science ®Google Scholar
• Van Thiel D H, Gavaler J S, Tarter R E, et al. Liver transplantation for alcoholic liver disease: a consideration of reasons for and against. Alcohol Clin Exp Res 1989; 13: 181–4
   PubMedGoogle Scholar
• Neuberger J M. Transplantation for alcoholic liver disease. Br Med J 1989; 299: 693–4
   PubMedGoogle Scholar
• Beresford T P, Turcotte J G, Merion R, et al. A rational approach to liver transplantation for the alcoholic patient. Psychosomatics 1990; 31: 241–54
   PubMedGoogle Scholar
• Doffoel M, Wolf P, Ellero B, et al. Results of orthotopic liver transplantation (OLT) in alcoholic cirrhosis. J Hepatol 1989; 9: 527, Suppl 1
   Google Scholar
• Kumar S, Stauber R E, Gavaler J S, et al. Orthotopic liver transplantation for alcoholic liver disease. Hepatology 1990; 11: 159–64
   PubMed Web of Science ®Google Scholar
• Stevens L, Piper J, Emond J, et al. Liver transplantation for controversial indications: alcoholic liver disease, hepatic cancers, and viral hepatitis. Transplantation Proc 1991; 23: 1915–6
   PubMedGoogle Scholar
• Van Thiel D H, Carr B, Iwatsuki S, et al. Liver transplantation for alcoholic liver disease, viral hepatitis, and hepatic neoplasms. Transplantation Proc 1991; 23: 1917–21
   PubMed Web of Science ®Google Scholar
• Ghabra N, Piraino B, Greenberg, Banner B. Resolution of cirrhotic glomerulonephritis following successful liver transplantation. Clin Nephrol 1991; 35: 6–9
   PubMedGoogle Scholar